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Abstract 
Objective: Many patients relapse within one year of completing effective cognitive 
behavioural therapy (CBT) for depression and anxiety. Residual symptoms at treatment 
completion have been demonstrated to predict relapse, and so this study used network 
analyses to improve specificity regarding which residual anxiety and depression symptoms 
predict relapse. 
Method: A cohort study identified relapse cases following low- and high-intensity CBT in a 
stepped care psychological therapy service. The sample included N µUHFRYHUHG¶
treatment completers that attended a six-month follow-up review. At follow-up, N=93 
patients had relapsed and N=774 remained in-remission. Networks of final treatment session 
depression (PHQ-9) and anxiety (GAD-7) symptoms were estimated for both sub-groups. 
Results: Qualitatively similar symptom networks were found. Difficulty concentrating was a 
highly central symptom in the relapse network, whilst of only average centrality in the 
remission network. In contrast, trouble relaxing was highly central in the remission network, 
whilst of only average centrality in the relapse network. 
Discussion: Identification of central residual symptoms holds promise in improving the 
specificity of prognostic models and the design of evidence-based relapse prevention 
VWUDWHJLHV7KHVPDOOVDPSOHRIUHODSVHFDVHVOLPLWVWKLVVWXG\¶VDELOLW\WRGUDZILUP
conclusions. 
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Introduction 
Depression and anxiety disorders are associated with high rates of relapse (< 12 
PRQWKVDQGUHFXUUHQFHPRQWKVDIWHUWUHDWPHQW%RFNWLQJ+ROORQ-DUUHWW.X\NHQ	
Dobson, 2015; Bruce et al., 2005; Burcusa & Iacono, 2007; Hardeveld, Spijker, De Graaf, 
Nolen & Beekman, 2010; Vervliet, Craske & Hermans, 2013). Cognitive behavioural therapy 
(CBT) is an effective acute-phase intervention (i.e. the period in which patients are actively 
experiencing a clinically significant problem; Kupfer, 1991) for depression and anxiety 
problems, and it has been shown to produce lower relapse rates compared to 
pharmacotherapy (Cuijpers et al., 2013; Hollon, Stewart & Strunk, 2006; Otto, Smits & 
Reese, 2005; Vittengl, Clark, Dunn & Jarrett, 2007). Despite this, many patients with 
apparently successful outcomes relapse quickly after completing either high- or low-intensity 
CBT. For example, a meta-analysis found that 29% of patients relapse within one year of 
high-intensity CBT, and this increases to 54% within two years if recurrence events are also 
considered (Vittengl et al., 2007). In low-intensity CBT (i.e. brief guided self-help), 53% of 
patients with remission of symptoms were found to relapse within one year, with a further 
13% experiencing a recurrence within two years (Ali et al., 2017; Delgadillo et al., 2018). 
These findings suggest that treatment gains for some patients are not sustained following 
CBT, which raises a need to better understand how to improve the longer-term benefits of 
therapy.   
Residual symptoms at the end of CBT treatment have been found to predict relapse 
(see meta-analysis by Wojnarowski, Firth, Finegan, & Delgadillo, 2019). The level of 
residual symptoms is typically estimated with sum-scores of standardized outcome measures 
computed across a set of individual symptom scores (Fried & Nesse, 2015b). Calculating 
sum-scores in this manner presupposes that symptoms develop from a common cause and 
that all the symptoms of a disorder are interchangeable and equally important indicators of 
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severity. However, there are reasons to question these assumptions (Fried & Nesse, 2015b). 
For example, it has been argued that there are approximately 1000 unique symptom profiles 
that all meet the criteria for a diagnosis of major depression according to the DSM-5 (APA, 
2013) definition (Fried & Nesse, 2015a). Moreover, the typical sum-score approach is usually 
based on a reflective measurement model that regards observed variables (such as item 
scores) as emanating from a common underlying latent construct. From this standpoint, 
individual symptoms do not directly interact but are rather assumed to be statistically 
independent when their common underlying cause is taken into account. This assumption is 
frequently at odds with clinical experience in that at least some symptoms (e.g. insomnia) are 
reported to have causal relationships with other symptoms (e.g. fatigue; Ferentinos et al., 
2009; Fried & Nesse, 2015b).  
Using sum-scores to aggregate across variables that may be functionally related may 
obscure potentially important individual differences in patterns of contingencies between 
symptoms that may represent relapse signatures (i.e. processes, factors and choices that 
signal the risk of imminent relapse). The identification of such key symptom interactions 
could EHWWHUVXSSRUWWKHLQYHVWLJDWLRQRIWKHRULHVVXFKDVWKHµNLQGOLQJ¶DSSURDFKWRUHODSVHLQ
depression (Stroud, Davila & Moyer, 2008). 
The network approach to psychopathology (Borsboom & Cramer, 2013) was 
developed as an alternative to the standard measurement approach in the field based on latent 
variables and sum scores. Notably, networks accommodate the possibility of local 
interactions between variables measured by individual scale indicators. Network models 
consist of nodes (i.e. items on measures representing specific symptoms) and edges (i.e., the 
connections between nodes). According to the network approach, symptom covariance is not 
assumed to stem from a common cause, but rather reflects that symptoms are connected in a 
dynamic network of direct and indirect causal interactions. One symptom can trigger a causal 
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chain involving other symptoms being reciprocally elicited and vicious cycles to be 
HVWDEOLVKHGWKDWSDWLHQWVILQGKDUGWREUHDNRUDOWHUHJLQVRPQLDĺFRQFHQWUDWLRQSUREOHPV
ĺZRUWKOHVVQHVVĺGHSUHVVHGPRRGĺLQVRPQLD6XFKIHHGEDFNORRSVZLWKLQV\PSWRP
networks result in symptoms co-evolving and becoming self-sustaining, potentially resulting 
in a characteristic pattern of symptoms that create a diagnosable mental disorder (Borsboom, 
2017). 
There has been a significant increase in clinical research adopting the network 
approach within the last decade (see Fried et al., 2017, for a review). For example, in relation 
to studying remission, von Borkulo et al. (2015) explored N=515 patients who were 
experiencing at least moderate depressive symptoms, and who had been diagnosed with 
depression in the previous 12 months. Baseline symptom networks (11 symptoms) were 
compared between patients still suffering from depression two years after baseline (i.e. 
µSHUVLVWHUV¶N DQGWKRVHZKRKDGUHFRYHUHGDIWHUWZR\HDUVLHµUHPLWWHUV¶N=262). 
$WEDVHOLQHLQWKHSHUVLVWHUV¶QHWZRUNV\PSWRPVZHUHVLJQLILFDQWO\PRUHFRQQHFWHGLH
FRUUHODWHGZLWKHDFKRWKHUWKDQWKHUHPLWWHUV¶QHWZRUN,QSDUWLFXODUV\PSWRPVRIµIDWLJXH¶
DQGµJXLOW¶ZHUHPRUHFHQWUDOLHPRUHFRUUHODWHGZLWKRWKHUV\PSWRPVLQWKHSHUVLVWHUV¶
QHWZRUNWKDQLQWKHUHPLWWHUV¶QHWZRUN7KLVVWXG\LOOXVWUDWHVWKHSRWHQWLDOXVHIXOQHVVRIWKH
network approach in its ability to explore numerous symptoms and their interrelationships - a 
fundamental challenge of psychotherapy research - and its potential for generating testable 
hypotheses related to these variables. There are no alternative analytic strategies available at 
present to our knowledge that offer comparable capabilities. 
7KLVH[SORUDWRU\µSURRI-of-FRQFHSW¶VWXG\DSSOLHGDQHWZRUNDSSURDFKWRLQYHVWLJDWH
the role of residual symptoms in predicting relapse of depression and anxiety following CBT.  
Network analyses were conducted to compare the symptom network structures of cases that 
did and did not experience a relapse of depression and/or anxiety symptoms within six 
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months of completing low- and high-intensity forms of CBT. These analyses aimed to 
identify specific symptoms that may be highly connected in the relapse network, but not as 
connected to the same degree in the remitters network. This would therefore highlight 
symptoms that potentially play a role in relapse. Identifying such symptoms could provide 
valuable targets for relapse prevention interventions applied during the acute-phase of 
treatment and then applied by patients thereafter. 
Method 
Design and Setting 
This study analysed data previously collected for a naturalistic, prospective cohort 
study conducted by Wojnarowski, Kellett, Sainty and Delgadillo (under review). This data was 
collected from a single psychological therapy service in the north of England within the 
Improving Access to Psychological Therapies programme (Clark, 2011). The study had ethical 
approval from an independent Research Ethics Committee and the NHS Health Research 
$XWKRULW\ 5HI :$ ,$37 XVHV D µVWHSSHG FDUH¶ VHUYLFH GHOLYHU\ V\VWHP WKDW
implements National Institute for Health and Clinical Excellence (NICE; 2011) guidelines for 
the treatment of depression and anxiety (Clark, 2011). In stepped care, patients are initially 
offered low-intensity guided self-help interventions, and if patients do not respond to this initial 
step they are subsequently offered high-intensity psychological interventions. The first-line 
treatments within IAPT are CBT-based low and high intensity interventions, however other 
high intensity interventions (e.g. interpersonal therapy) are also offered. Low-intensity CBT in 
this service was highly standardized, brief (< eight sessions), psycho-educational support 
offered by qualified psychological wellbeing practitioners trained to a national curriculum and 
in receipt of weekly case management supervision driven by outcome monitoring (National 
IAPT Team, 2015). High-intensity CBT (up to 20 sessions) was delivered by qualified and 
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accredited cognitive behavioural psychotherapists following disorder-specific and protocol-
driven CBT models recommended in the CBT for anxiety and depression competency 
framework (Roth & Pilling, 2008).  
The service involved in this study started routinely offering follow-up review 
appointments to patients who successfully completed treatment (i.e. achieved remission of 
symptoms by the end of treatment) in 2013; data collection for this study began in 2013 and 
ended in 2015. The follow-up appointments were conducted by the same therapists that 
delivered treatment. Reviews took place within six months of this final session, however the 
exact timing was negotiated between therapist and client to occur at a mutually agreeable 
time. As the timing of follow-up appointments was therefore flexible, there was significant 
variability in follow-up durations. This period ranged from one-to-six months, with the modal 
duration being four months (for approximately 60% of cases). Only data for cases in which 
the follow-up review occurred at least three months after the final treatment session were 
analysed. There were two reasons behind this approach. First, in some cases in which the 
timing between the final treatment session and follow-up review was shorter (e.g. one 
month), this length of time was not significantly different from the length of time between 
acute-phase treatment sessions. Furthermore, these cases were extreme outliers among the 
wider distribution. Second, in clinical trials, three months is frequently used as a short-term 
follow-up. 
Participants 
Participants were a subsample of cases from the cohort studied by Wojnarowski et al. 
(under review). The sample included data for N=867 patients, of whom N=93 (11%) were 
³UHODSVHGFDVHV´DQGN ZHUHFODVVHGDV³LQUHPLVVLRQ´7KLVZDVDVXEVHWRID
wider cohort (N=2899) of patients who completed low- and high-intensity CBT with full 
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remission of depression and anxiety symptoms. The subset used in the present study included 
only cases that attended scheduled follow-up review appointments to determine relapse 
status. Of the wider cohort, N=1348 patients were offered a follow-up review, with N=968 
attending. As this study only analysed data for cases in which the follow-up review occurred 
at least three months following treatment completion, N=868 of the N=968 cases were 
eligible for analysis. One of these cases had missing item-level data for the PHQ-9 and GAD-
7 for the final treatment session, meaning they could not be included in the network analyses. 
This resulted in the final sample of N=867 patients. Further details about the wider cohort are 
reported by Wojnarowski et al. (under review).  
Fourteen different primary mental health problems were recorded for patients 
included in this study sample, with the three most common being: mixed anxiety and 
depression (40.7%); depressive episode (18%); and generalised anxiety disorder (15.8%). 
Within the included sample: 33% were male; the mean age at referral was 44 (SD = 16.3); 
99% were white British; 11% were unemployed; and 67% received high-intensity CBT, 
while 33% received low-intensity CBT. Table 1 contains the demographic information and 
mean outcome scores from different time points of the relapse and remission subsamples. 
Primary Outcome Measures 
Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001): A nine-
item screening tool for major depression based on the symptoms listed in the DSM-5 (Table 
2). Each item assesses the frequency that patients experience a specific symptom over a 
period of two weeks on a scale ranging from 0-LHµQRWDWDOO¶WRµQHDUO\HYHU\GD\¶7KH
maximum score that can be obtained for this measure is 27, and the recommended diagnostic 
cut-off criteULDIRUPDMRUGHSUHVVLRQLVDVFRUHRI1+67KH&URQEDFK¶VDOSKDIRU
the PHQ-LQWKLVVWXG\¶VVDPSOHZDV 
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Generalized Anxiety Disorder scale (GAD-7; Spitzer, Kroenke, Williams & Lowe, 
2006): A seven-item screening tool for anxiety disorders (Table 2). Similar to the PHQ-9, 
each item assesses the frequency that specific anxiety symptoms are experienced over a 
period of two weeks, and the same scale as the PHQ-9 (i.e. 0-3) is used. The maximum score 
that can be obtained from the GAD-7 is 21, and the recommended cut-off for the detection of 
DQDQ[LHW\GLVRUGHULVDVFRUHRI1+67KH&URQEDFK¶VDOSKDIRUWKH*$'-7 in this 
VWXG\¶VVDPSOHZDV 
In order to assess reliable change in the above measures as part of routine outcome 
monitoULQJ5LFKDUGVDQG%RUJOLQSURSRVHGUHOLDEOHFKDQJHLQGLFHVRIIRU3+4-9 
DQGIRU*$'-7. 
These self-administered outcome measures are collected at every session in IAPT 
VHUYLFHVWRPRQLWRUDSDWLHQW¶VUHVSRQVHWRWUHDWPHQW&ODUN7DEOH2 contains the item 
numbers and associated symptoms for the PHQ-9 and the GAD-7. Scores from these 
measures from three different time points were analysed in this study: 1) baseline scores from 
the initial assessment; 2) scores from the final acute-phase treatment session; and 3) scores 
from follow-up review appointments. 
Relapse was defined following the method proposed by Delgadillo et al. (2018). 
Three criteria had to be met for a patient to be classed as having relapsed: a) their PHQ-9 and 
GAD-VFRUHVIURPWKHILQDOVHVVLRQZHUHEHORZWKHUHVSHFWLYHPHDVXUHV¶GLDJQRVWLc cut-off 
criteria; b) at least one of their PHQ-9 or GAD-7 scores was above the cut-offs at the follow-
up review; and c) any outcome score at follow-up that was above the cut-off also displayed 
statistically reliable deterioration (i.e. an increase greater or equal to the reliable change 
index) in comparison to the final treatment session. Patients with an outcome measure score 
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above the diagnostic cut-off at follow-up, which did not display clinically significant 
deterioration, were classed as remaining in-remission.  
Network Estimations 
First, network structures of baseline PHQ-9 and GAD-7 symptoms were estimated 
separately for relapse and remission samples. From the study subsamples of N=93 relapsed 
patients and N=774 patients in remission, two relapsed patients and five remitted patients did 
not have available baseline item-level data. Therefore, a baseline symptom network model 
was estimated using data from N=91 relapsed patients, while another network model was 
estimated using data from N=769 remitted patients. These networks were qualitatively 
compared to explore whether there were differences in terms of symptom profiles at the 
beginning of treatment. Following this, network structures of symptoms displayed at the final 
treatment session were also estimated separately for the total relapse and remission samples. 
Network models were estimated using the R package qgraph (Epskamp, Cramer, 
Waldorp, Schmittmann & Borsboom, 2012). When using qgraph, the settings were 
customised to display red edges to represent negative partial correlations, and green edges to 
represent positive partial correlations. Stronger partial correlations are represented by more 
saturated and wider edges. The edges were estimated using regularized partial correlations 
between symptoms. The calculation of partial, rather than zero-order, correlations meant that 
edges present in a network represent relationships between two nodes when the influence of 
all other nodes in the network was controlled (Epskamp & Fried, 2018). Each network was 
initially estimated using partial polychoric correlations, which is a technique of correlation 
estimation that can be used for ordinal variables. Polychoric correlations are calculated by 
estimating the correlation between two unobserved but theorised normally distributed 
continuous variables that are assumed to underlie observed ordinal variables (Salkind, 2010). 
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Following the estimation of networks based on partial polychoric correlations, we then re-
estimated each network based on partial Spearman correlations. Epskamp and Fried (2018) 
recommend this procedure so that networks derived from both types of correlation matrices 
can be compared. If they do not appear to be similar, this indicates potential artefacts arising 
from the estimation of polychoric correlations and consequently casts doubt on the resulting 
network structure, thus suggesting that Spearman correlation networks should be used. 
As the production of networks involves the estimation of a significant number of 
parameters (i.e. 136 parameters for a network containing 16 nodes; Beard et al., 2016), it is 
likely that some false-positive edges are produced. The network models were therefore 
regularized by applying the graphical LASSO (i.e. Least Absolute Shrinkage and Selection 
Operator) algorithm to eliminate likely false-positive edges from the estimated networks 
(Friedman, Hastie & Tibshirani, 2008). Application of the Graphical LASSO algorithm thus 
produces a sparse, more conservative network containing the smallest number of edges 
needed to explain the covariance of nodes. 
The R package qgraph (Epskamp et al., 2012) automatically applies the graphical 
LASSO algorithm in combination with Extended Bayesian Information Criterion (EBIC; 
Chen & Chen, 2008) model selection. The EBIC encompasses a hySHUSDUDPHWHUȖJDPPD
which is set manually by the researcher, that determines to what degree simpler models 
(fewer edges) should be preferred by the EBIC. The hyperparameter is typically set between 
0 and 0.5, with higher values indicating a preference for simpler, more conservative models 
(SVNDPS	)ULHG'XHWRWKLVVWXG\¶VH[SORUDWRU\QDWXUHȖZDVVHWWRIRUDOO
estimated networks to err on the side of discovery.1 
                                                          
1
 When Ȗ WKHHVWLPDWHGQHWZRUNIRUWKHUHODSVHVDPSOHFRQWDLQHGRQO\VL[HGJHV7KHHVWLPDWHG
QHWZRUNIRUWKHUHPLVVLRQVDPSOHZDVKLJKO\VLPLODUWRWKHRQHHVWLPDWHGZKHQȖ  
12 
 
 To assist with comparisons between symptom networks at the final treatment session 
of subsequent relapse and remission samples, three indices of node centrality were calculated 
to identify the most central symptoms of the network (McNally, 2016). For each node, the 
centrality indices calculated were: strength, which denotes the absolute sum of edge weights 
(i.e. correlation coefficients) connected to a node; betweenness, which represents the number 
of times a node is present on the shortest path between two other nodes; and closeness, which 
signifies the average distance from one node to other nodes in the network. Differences in 
central symptoms at the final treatment session between remission and relapse samples could 
indicate symptoms associated with relapse.  
Network Stability 
Finally, the stability of each estimated network was assessed in two stages. First, to 
assess the stability of network edges, a bootstrap approach was adopted to calculate 95% 
confidence intervals for edge values. Second, to assess WKHVWDELOLW\RIDQHWZRUN¶VFHQWUDOLW\
indices, a case-dropping bootstrap was performed. In this process, the centrality measures 
derived from the complete dataset were repeatedly correlated with centrality measures 
derived from a subsample that had a percentage (e.g. 10% or 40%) of participants or nodes 
missing. If correlation coefficients decrease significantly as nodes or participants are 
removed, the centrality measure is considered unstable. The results of the case-dropping 
bootstrap can be summarized in a coefficient called the correlation stability coefficient (CS-
coefficient), which should be at least 0.25 for a centrality index to be considered stable, but 
should ideally be above 0.5. Both stages of stability assessments were completed using the R 
package bootnet (Epskamp, Borsboom & Fried, 2017). 
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Results 
Preliminary Analysis 
Comparisons of the patient characteristics of the relapse and remission samples found 
no significant differences in terms of gender, ethnicity, employment status, and age 
respectively (all p > .05). However, a significant association was found between the intensity 
RIWUHDWPHQWDQGZKHWKHUDSDWLHQWUHODSVHGRUQRWȤ2(1, N = 867) = 5.31, p = .004, ĳ= .08); a 
higher proportion of relapsed patients (77%) received high-intensity CBT than remitted 
patients (66%). In addition, the relapse sample (M = 3.98; SD = 2.65) had significantly higher 
PHQ-9 scores at the end of treatment (t(865) = -2.80; p = .005) than the remission sample (M 
= 3.20; SD = 2.54). Similarly, the relapse sample (M = 3.52; SD = 2.19) also had significantly 
higher GAD-7 scores at treatment completion (t(865) = -2.72; p = .007) than the remission 
sample (M = 2.89; SD = 2.08). 
Network Differences at Baseline 
The networks of baseline symptoms based on polychoric correlations and the same 
QHWZRUNVEDVHGRQ6SHDUPDQ¶VFRUUHODWLRQVGLGQRWDSSHDUWRVXEVWDQWLDOO\GLIIHULQ
appearance (see Supplementary Materials A for comparisons). The networks based on 
6SHDUPDQ¶VFRUUHODWLRQVZHUHGHWHUPLQHGWREHWKHPRVWDSSURSULDte for baseline data, as 
these had higher stability compared to networks based on polychoric correlations. These 
networks were therefore examined in subsequent analyses. 
Figure 1 illustrates that the symptom network for the relapse sample (panel a) was 
highly similar to the symptom network for the remission sample (panel b) at the initial 
(baseline) assessment. Both networks appeared to have two distinct clusters of symptoms, 
with PHQ-9 symptoms primarily being more related with each other, and a similar pattern 
occurring with GAD-7 symptoms. The only moderately strong association existing between a 
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PHQ-9 symptom and a GAD-7 symptom for both networks was found to be between 
³SV\FKRPRWRUDJLWDWLRQGHILFLWV´MotorDQG³UHVWOHVVQHVV´Restless). 
Network Differences at Final Treatment Session 
 The networks of symptoms from the final treatment session based on polychoric 
correlations were substantially different from the same symptom networks based on 
6SHDUPDQ¶VFRUUHODWLRQVVHH6XSSOHPHQWDU\0DWHULDOV%IRUFRmparisons). These 
dissimilarities, along with the polychoric correlation networks being densely connected and 
including many unexpected negative edges, indicated that the polychoric correlations were 
untrustworthy (Epskamp & Fried, 2018). Therefore, networNVEDVHGRQ6SHDUPDQ¶V
correlations were deemed to be the most appropriate for symptoms from the final treatment 
session, and these networks were therefore examined and interpreted. 
 Figure 2 suggests that the symptom network for the final treatment sessions for the 
relapse sample (panel a) had substantially less connectivity than the symptom network for the 
remission sample (panel b). However, the lack of edges represented in the relapse network is 
likely explained by the relapse sample being too small, as networks based on small sample 
sizes have often been found to contain fewer edges (Epskamp & Fried, 2018). Indeed, 
regularization shrinks edges more if there is a small sample size to avoid false positives. 
 The edges present in the relapse network were also present in the remission network, 
indicating that the networks were fairly similar. However, two of the strongest associations 
present in the remission network failed to appear (even as weak associations) in the relapse 
network. These associations were EHWZHHQ³SV\FKRPRWRUDJLWDWLRQGHILFLWV´Motor) and 
³UHVWOHVVQHVV´RestlessDQG³WURXEOHVOHHSLQJ´SleepDQG³WURXEOHUHOD[LQJ´Relax). 
Strength was the only centrality index that was estimated to have sufficient stability 
for both the relapse network (CSFRU §DQGWKHUHPLVVLRQQHWZRUNCS(cor=0.7) §
15 
 
0.749). Therefore, this is the only centrality measure that will be discussed here (see Table 3). 
The strength measures for both networks were highly similar, with many symptoms having 
relatively similar level of centrality within the networks. However, two symptoms had highly 
FRQWUDVWLQJOHYHOVRIFHQWUDOLW\³7URXEOHUHOD[LQJ´Relax; an anxiety symptom), was the 
most central node in the remission network, but only the eighth most central node in the 
UHODSVHQHWZRUN0HDQZKLOH³WURXEOHFRQFHQWUDWLQJ´Concent; a depression symptom) was 
the second most central node in the relapse network while being only the eighth most central 
node in the remission network. 
Network Stability 
Bootstrapped 95% confidence intervals revealed the two estimated networks for the 
remission sample (i.e. symptoms at 1) baseline and 2) final treatment session) to be somewhat 
stable. However, the two estimated symptom networks for the relapse sample were unstable. 
Discussion 
This is the first study to apply network analysis to examine the symptom structure of 
relapse versus remission cases following routinely delivered CBT. Consistent with available 
evidence (Wojnarowski et al., 2019), this study demonstrated that patients who relapse have 
significantly higher levels of residual depression and anxiety symptoms at the final treatment 
session. This suggests that residual symptoms are not minor issues to be ignored by clinicians 
or noise in the psychometric measure, but rather an important prognostic indicator that a 
patient remains psychologically vulnerable and is therefore at potential risk of relapse.    
The pre-treatment symptom networks appeared to have highly similar structures. Both 
networks exhibited two distinct clusters of symptoms, with one cluster consisting of PHQ-9 
symptoms and the other cluster consisting of GAD-7 symptoms. This illustrates that at 
baseline, individual symptoms of depression and anxiety conformed to the expected factor 
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structures of affective and anxiety symptoms. The high similarity between the two baseline 
symptom networks indicates that patients that go onto relapse or remain in remission appear 
to have similar symptom profiles at the start of treatment.  
The relapse network based on symptoms assessed at the final treatment session 
FRQWDLQHGUHODWLYHO\IHZHUHGJHVGHVSLWHWKH(%,&K\SHUSDUDPHWHUȖEHLQJVHWWR
(consistent with a less restrictive model), which was a significant limitation and likely due to 
the small sample size (Epskamp & Fried, 2018). Inadequate sample sizes often lead to 
networks with relatively fewer edges as a consequence of regularization, which penalizes 
edge weights more when the sample is underpowered to avoid false positive associations. 
This process operates weOOZKHQWKH³WUXH´QHWZRUNLVVSDUVHEXWWKHUHLVDULVNZKHQXVLQJ
VPDOOVDPSOHVRIUHJXODUL]DWLRQUHWXUQLQJDVSDUVHQHWZRUNZKHQWKH³WUXH´QHWZRUNLVQRW
sparse. Epskamp, Kruis and Marsman (2017) describe a general rule of having at least as 
many observations as estimated network parameters (136 in this study), but they explain that 
this general rule also sometimes results in unstable estimates. Therefore, there are currently 
no clear guidelines on the required sample for stable network estimations. 
 The fact that sparse networks were not produced for the relapse sample at baseline 
may potentially be explained by the relatively restricted range of symptom scores at the end 
of treatment (below the diagnostic threshold). This did not occur at baseline for the relapse 
sample when symptom scores had a broader range and greater variance (see Supplementary 
Materials C). 
For the most part, the same edges were present in the remission and relapse networks 
and largely the same items were central in both networks, indicating that both networks were 
highly similar. However, some noticeable differences between the two networks were 
REVHUYHG)LUVWWZRRIWKHVWURQJHVWHGJHVEHWZHHQµpsychomotor agitation/deficits¶DQG
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µrestless¶DQGEHWZHHQµdisrupted sleep¶DQG µtrouble relaxing¶SUHVHQWLQWKHUHPLVVLRQ
network were not present, even as weak associations, in the relapse network and despite other 
edges being present in the network. Second, two symptoms had highly contrasting levels of 
centrality within the two QHWZRUNV2QHRIWKHVHV\PSWRPVZDVµtrouble concentrating¶
which was the second most central symptom in the relapse network, while being only the 
HLJKWKPRVWFHQWUDOV\PSWRPLQWKHUHPLVVLRQQHWZRUN0HDQZKLOHµtrouble relaxing¶ZDV
the most central symptom in the remission network, and only the eighth most central 
symptom in the relapse network. 
7KHSURPLQHQWFHQWUDOLW\RIµtrouble concentrating¶ZLWKLQWKHUHODSVHQHWZRUNPD\
suggest that activation of this symptom has stronger exacerbating effects on other symptoms 
for patients vulnerable to relapse, while activation does not possess these effects for patients 
WKDWDUHOHVVYXOQHUDEOHWRUHODSVH7KLVPD\WKHUHIRUHLQGLFDWHWKDWµtrouble concentrating¶LV
an important predictor of relapse, and potentially a worthwhile target for relapse prevention 
interventions. This suggests that on completion of apparently successful CBT, clinicians 
could routinely inquire about concentration difficulties. Indeed, Boschloo, van Borkulo, 
Borsboom, and Schoevers (2016) found that the four most central symptoms of depression in 
a non-clinical sample were most predictive of who would later develop depression, 
illustrating the potential predictive power of central symptoms.  
Meanwhile, it is more difficult to interpret the ILQGLQJWKDWµtrouble relaxing¶ZDVWKH
most central symptom in the remission network, while only possessing average centrality in 
the relapse network. It is possible that this was a false positive, and more research is needed 
to interpret this finding if indeed it should be replicated by others. Moreover, although a 
number of studies have confirmed the role of central symptoms as predictors and targets of 
treatment, other studies have shown these not to be superior predictors to simple sums and 
counts of symptoms (e.g. Rodebaugh et al., 2018). Additionally, a more fundamental critique 
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has recently appeared questioning the interpretation of centrality as representing causal 
influence between psychological phenomena (Bringmann et al, 2018). 
One potential approach to better test the centrality of depressive and anxious 
symptoms in predicting relapse, is to conduct a prospective study involving ecological 
momentary assessment (EMA) methods and associated dynamic network modelling (see Lutz 
et al., 2018, for an example application of this method). EMA enables an intensive real-time, 
within-VXEMHFWVUHSHDWHGDVVHVVPHQWRIDSDWLHQW¶VFXUUHQWWKRXJKWVIHHOLQJVDQGEHKDYLRXUV
typically collected using a mobile device (e.g. smartphone). The dynamic network model 
approach can then consider how symptoms interact and change over time within individuals 
to predict relapse (e.g. multilevel vector autoregressive models; mlVAR; Bringmann et al., 
2013). This approach enables the individual and temporal dynamics of patient symptoms to 
be explored, thus allowing for idiographic explorations. The mlVAR modelling of EMA data 
enables a dynamic symptom network to be estimated for each individual patient within a 
sample, and consequently the centrality measures of specific symptoms for each individual 
patient can then be extracted. This allows for predictive models including these centrality 
measures to be tested, allowing for the investigation of network metrics as potential 
predictors of relapse. 
To date, sum-scores of residual symptoms have been the most well-established 
SUHGLFWRURIUHODSVH7KHILQGLQJVRIWKLVVWXG\¶VQHWZRUNDQDO\VLVPD\LQGLFDWHWKDW
concentration deficits may play a unique role in the risk of relapse, and that this signal may 
have been obscured in studies that use sum-scores. However, this needs further replication 
and the use of EMA methods could help to establish if this signal is reliable and adds 
enhanced predictive or clinical value over and above the parsimonious risk factor of residual 
symptom sum-scores. 
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Limitations 
,WLVLPSRUWDQWWRFRQVLGHUWKDWWKLVVWXG\¶VILQGLQJVZHUHUHDFKHGWKURXJKDTXDOLWDWLYH
comparison of symptom networks. Ideally, the symptom networks would have been 
compared using quantitative methods. One method to accomplish this would be to conduct a 
permutation test called the Network Comparison Test (NCT; (van Borkulo et al., 2017). An 
NCT was not conducted in this study due to: (1) the significant difference between the 
relapse and remission sample sizes violating an important assumption of the test (Epskamp & 
Fried, 2018); and (2) the lack of variance in symptom scores across both subgroups (see 
6XSSOHPHQWDU\0DWHULDOV&SULPDULO\FDXVHGE\WKHSUHGRPLQDQFHRI³]HUR´VFRUHV1&7
analysis would require that further research exploring symptom network differences between 
relapse and remission samples are carried out using larger, similarly sized samples. The 
analysis of a larger and adequately powered sample would also allow for the networks to be 
estimated with the EBIC hyperparameter ȖVHWWRWKXVDOORZLQJIRUPRUHFDXWLRXVDQG
conservative models (i.e. less spurious edges included) to be produced. Considering these 
limitations, it is important for future research to replicate this study using larger samples. 
However, the use of larger samples may not fully address the issue regarding the lack 
of variance in symptom scores. This floor effect (zero scores) would likely persist in studies 
with larger samples, given the nature of the time point at which data is collected (i.e. when 
pDWLHQWVDWWDLQUHPLVVLRQRIV\PSWRPV7KHUHIRUHD³]HUR-LQIODWHG´1&7LVUHTXLUHGWRDOORZ
for the test to be conducted in this context, but unfortunately this is not currently available. 
Another limitation of this study is evidence of selection bias within the dataset. 
Previous analysis of the original sample found that patients with higher PHQ-9 scores at the 
final treatment session were less likely to be offered follow-up by therapists (Wojnarowski et 
al., under review). As residual symptoms appear to have a predictive role in relapse, it could 
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be assumed that many of the patients who were not offered follow-up relapsed. However, as 
these patients were not followed-up, their data could not be included in the present analysis. 
This study was also limited by the brief, highly variable follow-up durations (between 
one and six months). These limitations, as well as the selection bias, likely explain the low 
base rate of relapse observed in this study (i.e. 11% compared to rates of 30% in controlled 
trials of CBT, and 53% in a naturalistic study of low-intensity CBT; Ali et al., 2017; Vittengl 
et al., 2007). Follow-up appointments offered to every patient, conducted in a structured 
manner and at a longer period after the completion of treatment would likely observe a more 
typical relapse base rate. Future research in this area should involve structured and longer 
term follow-up periods. The inclusion of structured and validated clinical interviews at 
follow-up would also provide greater confidence that relapse had occurred, particularly when 
combined with the use of validated outcome measures. 
Finally, this study was unable to quantify variability in relapse rates that might be 
attributable to therapists, as data was not available regarding the therapists who provided 
treatment. It is also unclear what techniques would be available to estimate network models 
from a nested data structure. Nevertheless, an investigation into therapist effects of relapse 
would be an interesting direction for future research, particularly as therapist effects have 
been estimated to account for 6-7% of outcome variance for low-intensity CBT (Firth, 
Barkham, Kellett & Saxon, 2015). 
Clinical Implications 
The clinical implications of this study mainly relate to the need for (a) relapse 
prevention work being a valued and core component of treatment, (b) the offer of routine 
structured follow-up to identify patients at risk of relapse following treatment and (c) the 
potential for the provision of booster sessions that supplement structured follow-up.  
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Dynamic network modelling could prove important through the identification of central 
residual symptoms of depression and anxiety that improve the specificity of relapse 
prevention interventions. If such studies indeed identify certain symptoms or patterns to be 
significant predictors of relapse, this could help to guide post-WUHDWPHQWµERRVWHU¶
interventions for patients. Risk of relapse needs to be normalised in patient psychoeducation, 
VRWKDWSDWLHQWVGRQRWIHHODµIDLOXUH¶FRQFHUQLQJUHODSVing, and avoid seeking further help 
due to feeling ashamed.  Individuals who display the identified predictive symptoms can be 
LGHQWLILHGDVEHLQJµDWULVN¶E\VHUYLFHVDQGVXEVHTXHQWO\WDUJHWHGIRURIIHULQJERRVWHU
sessions and bespoke relapse prevention strategies. This would support patients in 
maintaining their treatment gains, consequently removing their need for further intensive 
WUHDWPHQWZKLFKFUHDWHVDµUHYROYLQJGRRU¶F\FOHLQPHQWDOKHDOWKFDUHVHUYLFHV 
Conclusion 
The estimated network models indicated that relapse and remission cases have highly 
similar symptom profiles at the end of treatment, despite relapse cases having higher 
summed-scores in depression and anxiety measures. Nevertheless, certain differences 
emerged, such as concentration deficits possessing high centrality in the relapse sample, but 
only average centrality in the remission sample. However, this study was limited by an 
underpowered relapse sample. Interpretations should therefore be considered with caution, as 
they represent the first step in using network theory to predict relapse following routinely 
delivered low- and high-intensity CBT. Further research is necessary to replicate this study 
using adequately powered samples, so that more stable, accurate relapse symptom networks 
can be estimated. The adoption of EMA methods and associated dynamic network modelling 
should also be a focus of future research. The network approach holds promise in improving 
our understanding of the role of residual symptoms in predicting relapse, and thus potentially 
providing more specificity to evidence-based relapse prevention work. 
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Clinical or Methodological Significance Summary 
 This is the first study to adopt a network approach to explore residual levels of 
specific depression and anxiety symptoms and their role in relapse following cognitive 
behavioural therapy. Concentration deficits emerged as a highly central symptom in cases 
that relapsed. Such research may help in identifying specific symptoms that are predictive of 
relapse, and as a consequence potentially improve the specificity of relapse prevention 
interventions. 
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Table 1 
 
Demographic Information and Mean Outcome Scores of Relapse and Remission Samples 
 Relapse Sample Remission Sample 
N 93 774 
Male 40% 32% 
Mean Age (SD) 47 (17.2) 44 (16.2) 
White British 99% 99% 
Unemployed 17% 11% 
Received High Intensity CBT At 
Treatment Completion 
77% 66% 
Received Low Intensity CBT At 
Treatment Completion 
23% 35% 
Mean PHQ-9 Score at Baseline 14.58 12.92 
Mean GAD-7 Score at Baseline 13.28 12.60 
Mean PHQ-9 Score at Final 
Treatment Session 
3.98 3.20 
Mean GAD-7 Score at Final 
Treatment Session 
3.52 2.89 
Mean PHQ_9 Score at Follow-
Up Appointment 
11.85 3.08 
Mean GAD-7 Score at Follow-
Up Appointment 
11.10 2.89 
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Table 2 
 
PHQ-9 and GAD-7 Items and their Corresponding Symptoms 
Item Symptom Network Label 
PHQ9_Q1 Low interest or pleasure Anhedon 
PHQ9_Q2 Feeling down, depressed or hopeless Depress 
PHQ9_Q3 Trouble sleeping Sleep 
PHQ9_Q4 Tired or little energy Energy 
PHQ9_Q5 Poor appetite/overeating Appetite 
PHQ9_Q6 Guilt Guilt 
PHQ9_Q7 Trouble concentrating Concent 
PHQ9_Q8 Psychomotor agitation/deficits Motor 
PHQ9_Q9 Suicidal thoughts Suicide 
GAD7_Q1 Nervous, anxious or on edge Nervous 
GAD7_Q2 Uncontrollable worry ConWor 
GAD7_Q3 Excessive worry about different things ExcWor 
GAD7_Q4 Trouble relaxing Relax 
GAD7_Q5 Restlessness Restless 
GAD7_Q6 Easily annoyed or irritated Annoyed 
GAD7_Q7 Afraid something awful might happen Afraid 
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Figure 1. Network of baseline PHQ-9 (blue) and GAD-7 (purple) symptoms for a) the 
relapse sample and b) the remission sample. 
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Figure 2. Network of PHQ-9 (blue) and GAD-7 (purple) symptoms at the final treatment 
session for a) the relapse sample and b) the remission sample. 
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Table 3 
 
Ranked Strength Values for each Node in the Relapse and Remission Networks of 
Symptoms at the Final Treatment Session sorted by Rank Discrepancy 
 Relapse Network Remission Network  
Symptom Strength Rank 
(Strength Value) 
Strength Rank 
(Strength Value) 
Strength Rank 
Discrepancy 
Relax 8 (0.540) 1 (1.048) 7 
Concent 2 (0.937) 8 (0.837) 6 
Anhedon 6 (0.585) 2 (1.031) 4 
Restless 7 (0.550) 11 (0.646) 4 
Energy 10 (0.449) 6 (0.891) 4 
Afraid 11 (0.445) 15 (0.511) 4 
Depress 1 (0.959) 4 (0.979) 3 
Annoyed 9 (0.450) 12 (0.627) 3 
Nervous 12 (0.376) 9 (0.776) 3 
Sleep 13 (0.274) 10 (0.751) 3 
ExcWor 5 (0.610) 7 (0.861) 2 
Guilt 4 (0.694) 5 (0.911) 1 
Motor 14 (0.140) 13 (0.576) 1 
Appetite 15 (0.081) 14 (0.537) 1 
ConWor 3 (0.744) 3 (1.000) 0 
Suicide 16 (0.000) 16 (0.175) 0 
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Figure A2. Network of baseline PHQ-9 (blue) and GAD-7 (purple) symptoms for the 
UHPLVVLRQVDPSOHXVLQJDSRO\FKRULFFRUUHODWLRQVDQGE6SHDUPDQ¶VFRUUHODWLRQV 
Figure A1. Network of baseline PHQ-9 (blue) and GAD-7 (purple) symptoms for the 
UHODSVHVDPSOHXVLQJDSRO\FKRULFFRUUHODWLRQVDQGE6SHDUPDQ¶VFRUUHODWLRQV 
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Figure B1. Network of PHQ-9 (blue) and GAD-7 (purple) symptoms at the final treatment 
VHVVLRQIRUWKHUHODSVHVDPSOHXVLQJDSRO\FKRULFFRUUHODWLRQVDQGE6SHDUPDQ¶V
correlations 
Figure B2. Network of PHQ-9 (blue) and GAD-7 (purple) symptoms at the final treatment 
session for the remission VDPSOHXVLQJDSRO\FKRULFFRUUHODWLRQVDQGE6SHDUPDQ¶V
correlations 
36 
 
 
Table C2 
 
Descriptive Statistics of PHQ-9 and GAD-7 Item Scores for the Remission Sample at 
Baseline and at Final Treatment Session 
 Baseline Scores Final Treatment Session Scores 
Item Range of Scores Mean Score (SD) Range of Scores Mean Score (SD) 
PHQ9-Q1 0-3 1.50 (1.01) 0-2 0.34 (0.49) 
PHQ9-Q2 0-3 1.67 (0.97) 0-3 0.45 (0.53) 
PHQ9-Q3 0-3 1.94 (1.08) 0-3 0.63 (0.73) 
PHQ9-Q4 0-3 1.98 (1.01) 0-3 0.69 (0.68) 
PHQ9-Q5 0-3 1.40 (1.15) 0-3 0.33 (0.57) 
PHQ9-Q6 0-3 1.71 (1.09) 0-2 0.32 (0.50) 
PHQ9-Q7 0-3 1.40 (1.07) 0-3 0.29 (0.49) 
PHQ9-Q8 0-3 0.88 (1.02) 0-2 0.11 (0.32) 
PHQ9-Q9 0-3 0.43 (0.77) 0-1 0.03 (0.16) 
GAD7-Q1 0-3 2.15 (0.93) 0-2 0.64 (0.53) 
GAD7-Q2 0-3 2.13 (0.94) 0-2 0.43 (0.51) 
GAD7-Q3 0-3 2.14 (0.94) 0-2 0.47 (0.51) 
GAD7-Q4 0-3 1.84 (1.00) 0-3 0.39 (0.53) 
GAD7-Q5 0-3 1.12 (1.04) 0-2 0.18 (0.40) 
GAD7-Q6 0-3 1.64 (1.06) 0-3 0.47 (0.42) 
GAD7-Q7 0-3 1.56 (1.13) 0-3 0.30 (0.50) 
 
Table C1 
 
Descriptive Statistics of PHQ-9 and GAD-7 Item Scores for the Relapse Sample at Baseline 
and at Final Treatment Session 
 Baseline Scores Final Treatment Session Scores 
Item Range of Scores Mean Score (SD) Range of Scores Mean Score (SD) 
PHQ9-Q1 0-3 1.70 (1.06) 0-1 0.40 (0.49) 
PHQ9-Q2 0-3 1.93 (0.99) 0-2 0.53 (0.60) 
PHQ9-Q3 0-3 2.05 (1.11) 0-3 0.80 (0.85) 
PHQ9-Q4 0-3 2.30 (0.93) 0-3 0.83 (0.70) 
PHQ9-Q5 0-3 1.37 (1.12) 0-3 0.41 (0.66) 
PHQ9-Q6 0-3 1.76 (1.17) 0-3 0.43 (0.62) 
PHQ9-Q7 0-3 1.66 (1.20) 0-2 0.40 (0.57) 
PHQ9-Q8 0-3 1.00 (1.03) 0-1 0.14 (0.35) 
PHQ9-Q9 0-3 0.55 (0.85) 0-1 0.05 (0.23) 
GAD7-Q1 0-3 2.30 (0.93) 0-2 0.74 (0.53) 
GAD7-Q2 0-3 2.16 (0.96) 0-2 0.52 (0.56) 
GAD7-Q3 0-3 2.24 (0.97) 0-2 0.56 (0.54) 
GAD7-Q4 0-3 1.97 (1.01) 0-2 0.45 (0.54) 
GAD7-Q5 0-3 1.34 (1.11) 0-2 0.25 (0.46) 
GAD7-Q6 0-3 1.85 (1.04) 0-3 0.63 (0.67) 
GAD7-Q7 0-3 1.56 (1.22) 0-1 0.37 (0.48) 
